Randomized, investigator blind, vehicle controlled study evalutating the safety, tolerability and pharmacokinetics of E6005 in healthy volunteers.

Trial Profile

Randomized, investigator blind, vehicle controlled study evalutating the safety, tolerability and pharmacokinetics of E6005 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Nov 2016

At a glance

  • Drugs RVT 501 (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 25 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top